While this is usually not a concern for a healthy heart, it is something that people with high blood pressure or tachycardia (a fast heart rate) need to discuss with their doctor
Step 5: Invert the vial so the stopper faces down
2: Reduction in Certain Diseases Recent clinical trial results suggest that the health impacts of GLP-1RAs go beyond weight loss, with the drug leading to a reduction in various diseases, such as cardiovascular disease or slowing down the progression of some illnesses such as chronic kidney disease
Understanding where the science is heading helps set realistic expectations about what we know now versus what we might learn soon
Eligible seniors and low-income individuals pay minimal co-payments ($0-$6.11 depending on program status), but coverage requires proof of diabetes diagnosis and failure to control blood sugar with metformin alone. British Columbia (PharmaCare): BCs PharmaCare plan covers Ozempic for Type 2 diabetes patients, specifically when first-line treatments like metformin havent achieved adequate blood sugar control. Quebec (RAMQ): Quebecs public prescription drug insurance plan provides coverage for Ozempic in diabetes patients, with co-payments up to 35% of the total cost depending on income level. Nationwide Reality: As of 2026, no provincial health plan covers Wegovy for weight loss , and GLP-1 medications are generally restricted to diabetes indications only
How can I cancel the subscription
